Breast cancer treatments available now in close proximity to the AKH in Hagen
In the city of Hagen, Germany, a significant effort is being made to combat breast cancer through early detection and timely intervention. The mammography screening program, now located at Grünstraße 29, directly at the Agaplesion Clinic Hagen (AKH), is designed to reduce breast cancer mortality by detecting cancers early when they are more treatable and survival rates are higher.
The benefits of participating in this program are numerous. Early detection of breast cancer improves treatment options and outcomes, and reduces breast cancer-related mortality due to timely diagnosis and management. Additionally, the program may identify high-risk individuals who may benefit from closer monitoring or preventive measures.
Modern devices in the digital age require only 30 percent of the radiation dose of older equipment, addressing concerns about radiation exposure during the examination. The breast is compressed between two plates, which can be uncomfortable or painful, but does not harm the breast. The flatter the breast is compressed, the less X-ray radiation is needed, and the more informative the image becomes.
Dr. Karsten Ridder, a radiologist and the physician responsible for the screening unit in Dortmund-Hagen, emphasizes the significance of the screening program and early detection in saving lives. He considers the expansion of the screening offer up to the age of 75 to be appropriate, and encourages all women to take advantage of the free offer and further reduce breast cancer mortality in the future.
Despite concerns about overdiagnoses in examinations offered every two years, Dr. Ridder dismisses such criticism, asserting that the program's benefits outweigh any potential drawbacks. The current participation rate nationwide is only about 50 percent, which is far too low, according to Dr. Ridder.
For more information about the Dortmund-Hagen screening unit and the nationwide program, visit www.mammo-doha.de. The move to the new premises aims to further improve medical diagnostics, increase accessibility, and comfort for participants.
Public figures like Angelina Jolie and Sylvie Meis, who have raised awareness due to personal experience, have also contributed to the increase in participation in mammography screening. The Medical Care Center (MVZ) Prof. Dr. Uhlenbrock and Partners, founded in 1993, offers medical services in radiology, radiation therapy, and nuclear medicine at 19 locations in the Ruhr area and Westphalia.
In 2006, Germany was the last in Europe in terms of breast cancer screening, but today, 50-year-olds also participate, with improved treatment options and healing chances. The close cooperation with the medical staff of the breast center in Hagen works well, ensuring that participants receive the best possible care.
By prioritizing early detection and timely intervention, the mammography screening program in Hagen is making a significant contribution to improving breast cancer survival rates in the population.
Engaging in this mammography screening program, primarily based in Hagen, Germany, contributes to the advancement of women's health and overall health-and-wellness, particularly in the area of breast cancer detection. By improving treatment options and outcomes, and reducing breast cancer-related mortality, the program underscores the importance of science and medical innovation in saving lives.
The recommendations of medical professionals, such as Dr. Karsten Ridder, suggest that increased participation in these nationwide screenings could further lower breast cancer mortality rates, enhancing the impact of science and health-and-wellness initiatives.
